NANP Polyclonal Antibody

NANP Polyclonal Antibody

The NANP Polyclonal Antibody is a highly specialized and meticulously developed product that offers exceptional performance in various scientific applications. With a volume of 200μL, this antibody is designed to provide researchers with an ample supply for their experimental needs.

This antibody boasts an impressive concentration of 1.14 mg/mL, ensuring optimal efficacy and accuracy in its intended applications. The high concentration allows for precise and reliable results, making it an invaluable tool for researchers in the field.

The NANP Polyclonal Antibody has been meticulously produced using state-of-the-art techniques and stringent quality control measures. It is derived from a polyclonal source, ensuring a diverse range of antibodies that target the NANP antigen with exceptional specificity and affinity.

This antibody is suitable for a wide range of applications, including immunohistochemistry, western blotting, and enzyme-linked immunosorbent assays (ELISA). Its versatility allows researchers to explore various experimental approaches and obtain reliable and reproducible results.

The NANP Polyclonal Antibody is supplied in a convenient 200μL volume, providing researchers with an ample amount for multiple experiments. The antibody is stored in optimal conditions to maintain its stability and functionality, ensuring consistent performance over time.

Researchers can trust in the quality and reliability of this antibody, as it has undergone rigorous testing to ensure its specificity and performance. Each batch is carefully evaluated to meet the highest standards of quality, ensuring consistent and reproducible results.

In summary, the NANP Polyclonal Antibody is a highly concentrated and meticulously produced product that offers exceptional performance in a wide range of scientific applications. With its high specificity, versatility, and reliable results, this antibody is an indispensable tool for researchers seeking to advance their scientific endeavors.